Trial Profile
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Ketorolac; Prednisolone acetate
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 24 Apr 2015 New trial record